| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 165 |
| 1 | IBUPROFEN | 158 |
| 2 | PREDNISONE | 139 |
| 3 | IBUPROFEN ORAL | 124 |
| 4 | IBUPFROFEN | 123 |
| 5 | IBUPROFEN 200 MG | 123 |
| 6 | IBUPROFEN 200MG | 123 |
| 7 | IBUPROFEN CAPSULE | 123 |
| 8 | IBUPROFEN CAPSULES 200 MG | 123 |
| 9 | IBUPROFEN TABLET, FILM COATED | 123 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SUNVOZERTINIB | 3 | 0.0732 |
| 1 | CLOTRIMAZOLE1% CLOTRIMAZOLE | 1 | 0.0182 |
| 2 | ACETAMINOPHEN AND ASPIRIN AND CAFFEINE | 2 | 0.0124 |
| 3 | BENZNIDAZOLE | 1 | 0.0098 |
| 4 | RAMUCIRUMAB | 53 | 0.0084 |
| 5 | LEVAMLODIPINE | 1 | 0.0080 |
| 6 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| 7 | ERAVACYCLINE | 2 | 0.0067 |
| 8 | HALOBETASOL PROPIONATE AND TAZAROTENE | 1 | 0.0051 |
| 9 | MITOMYCIN | 18 | 0.0049 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 423 |
| 1 | Corticosteroid [EPC] | 391 |
| 2 | Platinum-based Drug [EPC] | 248 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 199 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 171 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 134 |
| 6 | Kinase Inhibitor [EPC] | 131 |
| 7 | Microtubule Inhibitor [EPC] | 128 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 119 |
| 9 | Alkylating Drug [EPC] | 106 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 53 | 0.0084 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 17 | 0.0029 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 4 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 9 | 0.0022 |
| 5 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 3 | 0.0020 |
| 6 | Provitamin D2 Compound [EPC] | 48 | 0.0016 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 14 | 0.0016 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 134 | 0.0014 |
| 9 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 4 | 0.0012 |